EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 67 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $50 | -88.1% | 71,700 | -84.7% | 0.00% | -100.0% |
Q1 2023 | $419 | +15.4% | 467,682 | +52.2% | 0.00% | – |
Q4 2022 | $363 | -100.0% | 307,300 | +131.3% | 0.00% | -100.0% |
Q3 2021 | $888,000 | +210.5% | 132,884 | +295.2% | 0.00% | – |
Q2 2021 | $286,000 | -69.8% | 33,625 | -68.5% | 0.00% | -100.0% |
Q1 2021 | $946,000 | -48.7% | 106,884 | -60.6% | 0.00% | -50.0% |
Q1 2020 | $1,844,000 | -13.5% | 271,184 | +89.5% | 0.00% | 0.0% |
Q4 2019 | $2,133,000 | +3.3% | 143,129 | -28.9% | 0.00% | 0.0% |
Q3 2019 | $2,064,000 | -34.8% | 201,329 | -32.6% | 0.00% | -33.3% |
Q2 2019 | $3,165,000 | -18.8% | 298,613 | +7.1% | 0.00% | -25.0% |
Q1 2019 | $3,899,000 | +51.6% | 278,929 | +10.2% | 0.00% | +33.3% |
Q4 2018 | $2,572,000 | -23.1% | 253,129 | -9.2% | 0.00% | 0.0% |
Q3 2018 | $3,346,000 | -24.4% | 278,813 | -29.3% | 0.00% | +50.0% |
Q2 2018 | $4,425,000 | +173.8% | 394,258 | +140.4% | 0.00% | 0.0% |
Q1 2018 | $1,616,000 | +19.4% | 164,029 | +69.1% | 0.00% | +100.0% |
Q4 2017 | $1,353,000 | +55.7% | 97,013 | +22.8% | 0.00% | 0.0% |
Q3 2017 | $869,000 | +369.7% | 79,013 | +237.3% | 0.00% | – |
Q2 2017 | $185,000 | – | 23,425 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
RA Capital Management | 354,200 | $4,056,000 | 0.50% |
DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |